Combining MIGS With Implant Lowers IOP in Glaucoma - Top_Thought_Leaders - MDSpire

Combining MIGS With Implant Lowers IOP in Glaucoma

“Data show incorporating iStent Infinite with cataract surgery, with or without iDose TR, significantly lowers IOP and reduces topical medication needs,” said Dr. Lisa Feulner in her presentation.

  • By

  • Julie Greenbaum, editor

  • Julie Greenbaum, editor

  • April 11, 2026

  • 4 min

Share

Top Thought Leaders in Ophthalmology

Brief introduction explaining scope and methodology.

Original Source(s)

Combining MIGS With Implant Lowers IOP in Glaucoma

  • by Julie Greenbaum, editor, Julie Greenbaum, editor

  • April 11, 2026

Related Content

Trends and Regional Differences in the Prescription of Prostaglandin Analogs for Glaucoma in England from 2019 to 2024

AI Supports Glaucoma Surgical Planning

Predictive models identify high-risk patients and support earlier treatment decisions.

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models